お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
997495

合法大麻の世界市場

Legal Marijuana

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 146 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.66円

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

合法大麻の世界市場
出版日: 2021年04月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 146 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の合法大麻の市場規模は、分析期間(2020年~2027年)に20.9%のCAGRで成長する見通しで、2020年の242億米ドルから、2027年には912億米ドルに達すると予測されています。

当レポートで分析されているセグメントの1つである医療用大麻は、分析期間中に20.6%のCAGRで成長し、690億米ドルに達すると予測されています。

当レポートは、世界の合法大麻市場について調査しており、市場シェア、Covid-19の影響、動向や成長要因、地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

調査対象企業の例

  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation

目次

I. 調査手法

II. エグゼクティブサマリー

  • 市場概要
    • インフルエンサー市場の洞察
    • 世界市場の軌跡
    • Covid-19の影響と迫り来る世界の景気後退
  • 主要企業
  • 動向と推進要因
  • 世界市場の見通し

III. 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

IV. 競合

  • 企業プロファイル:46社
目次
Product Code: MCP12993

Abstract:

Global Legal Marijuana Market to Reach $91.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Legal Marijuana estimated at US$24.2 Billion in the year 2020, is projected to reach a revised size of US$91.2 Billion by 2027, growing at aCAGR of 20.9% over the period 2020-2027. Medical Marijuana, one of the segments analyzed in the report, is projected to record 20.6% CAGR and reach US$69 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Recreational Marijuana segment is readjusted to a revised 21.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.2 Billion, While China is Forecast to Grow at 20.1% CAGR

The Legal Marijuana market in the U.S. is estimated at US$7.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$15.6 Billion by the year 2027 trailing a CAGR of 20.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 18.7% and 18.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 15.4% CAGR.

Select Competitors (Total 46 Featured) -

  • Aphria Inc.
  • Aurora Cannabis, Inc.
  • Beacon Medical
  • Canopy Growth Corporation
  • Cronos Group
  • OrganiGram Holdings, Inc.
  • Tikun Olam Ltd.
  • Tilray, Inc.
  • Wayland Group Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Current & Future Analysis for Legal Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 2: World 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
    • TABLE 3: World Current & Future Analysis for Medical Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 4: World 7-Year Perspective for Medical Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 5: World Current & Future Analysis for Recreational Marijuana by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 6: World 7-Year Perspective for Recreational Marijuana by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 7: World Current & Future Analysis for Chronic Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 8: World 7-Year Perspective for Chronic Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 9: World Current & Future Analysis for Mental Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 10: World 7-Year Perspective for Mental Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 11: World Current & Future Analysis for Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 12: World 7-Year Perspective for Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
    • TABLE 13: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 14: World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027

III. MARKET ANALYSIS

  • UNITED STATES
    • TABLE 15: USA Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 16: USA 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 17: USA Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 18: USA 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • CANADA
    • TABLE 19: Canada Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 20: Canada 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 21: Canada Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 22: Canada 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • JAPAN
    • TABLE 23: Japan Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 24: Japan 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 25: Japan Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 26: Japan 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • CHINA
    • TABLE 27: China Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 28: China 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 29: China Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 30: China 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • EUROPE
    • TABLE 31: Europe Current & Future Analysis for Legal Marijuana by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
    • TABLE 32: Europe 7-Year Perspective for Legal Marijuana by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
    • TABLE 33: Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 34: Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 35: Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 36: Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • FRANCE
    • TABLE 37: France Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 38: France 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 39: France Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 40: France 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • GERMANY
    • TABLE 41: Germany Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 42: Germany 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 43: Germany Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 44: Germany 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • ITALY
    • TABLE 45: Italy Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 46: Italy 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 47: Italy Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 48: Italy 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • UNITED KINGDOM
    • TABLE 49: UK Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 50: UK 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 51: UK Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 52: UK 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 54: Rest of Europe 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 55: Rest of Europe Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 56: Rest of Europe 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • ASIA-PACIFIC
    • TABLE 57: Asia-Pacific Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 58: Asia-Pacific 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 59: Asia-Pacific Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 60: Asia-Pacific 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027
  • REST OF WORLD
    • TABLE 61: Rest of World Current & Future Analysis for Legal Marijuana by Type - Medical Marijuana and Recreational Marijuana - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 62: Rest of World 7-Year Perspective for Legal Marijuana by Type - Percentage Breakdown of Value Sales for Medical Marijuana and Recreational Marijuana for the Years 2020 & 2027
    • TABLE 63: Rest of World Current & Future Analysis for Legal Marijuana by Application - Chronic Pain, Mental Disorders, Cancer and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
    • TABLE 64: Rest of World 7-Year Perspective for Legal Marijuana by Application - Percentage Breakdown of Value Sales for Chronic Pain, Mental Disorders, Cancer and Other Applications for the Years 2020 & 2027

IV. COMPETITION

  • Total Companies Profiled: 46
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.